Pylopass™- Lactobacillus reuteri
- Patented strain
- More than ≥ 1 x1011 inactivated cells/gram
- Unique mode of action for control of Helicobacter pylori
- 6 clinical study
Based in Berlin, Novozymes Berlin GmbH specialises in research and development into probiotics for the food-processing industry, pharmaceuticals, health, animal and human nutrition.
Novozymes offers probiotics having a beneficial effect on gastrointestinal health.
Founded in 2001, the company relies on its own collection of strains to develop and market unique, effective and patentable products.
It has a diverse collection of yeasts and lactobacilli, the first of which date back to the 1920s.
Since September 2016, Novozymes Berlin GmbH, formerly called Organobalance, has been part of the Novozymes group, leader in the field of biotechnology and a specialist in enzymes.
Visit their web site for more information.